Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Altered glymphatic system in idiopathic normal pressure hydrocephalus110
Linear predictive coding distinguishes spectral EEG features of Parkinson's disease86
Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease78
Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging71
Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features70
Gut microbiome in Parkinson's disease: New insights from meta-analysis68
Unmet needs in Parkinson disease: Motor and non-motor67
The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic49
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression48
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study47
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study46
COVID-19 in Parkinson's disease: Report on prevalence and outcome45
Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease42
Probiotics for constipation and gut microbiota in Parkinson's disease41
Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study39
Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?39
Tau and MAPT genetics in tauopathies and synucleinopathies37
Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s disease35
How do adenosine A2A receptors regulate motor function?35
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease34
Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis34
Effects of cerebellar transcranial magnetic stimulation on ataxias: A randomized trial34
The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant34
Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism33
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis33
Prediabetes, type 2 diabetes mellitus and risk of Parkinson’s disease: A population-based cohort study32
The use of wearable/portable digital sensors in Huntington's disease: A systematic review32
Impact of home confinement during COVID-19 pandemic on Parkinson's disease32
Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive review31
Parkinson's disease and skin31
Predicting Parkinson's disease using gradient boosting decision tree models with electroencephalography signals31
0.03369402885437